Abstract

Peanut-reactive (pr) CD4+ T cells are pivotal for the onset of peanut allergy as well as for peanut oral immunotherapy (OIT)-induced desensitization (DS). However, the underlying immune mechanism of how pr CD4+ T cells impact the development of sustained unresponsiveness (SU) following a period of avoidance is largely unknown. To this end, we probed pr CD4+ T cells from the phase 2 peanut OIT trial- POISED participants, who achieved SU vs. those who did not (termed as SU and DS participants respectively based on no vs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call